Neurology journal broadens recruitment efforts for clinical research trials

ST. PAUL, Minn. – Clinical research trials are a key part of the process of developing new treatment therapies for numerous neurological disorders. Clinical trials need not just patients but patients that meet the strict eligibility requirements in well-designed controlled trials. With the July 13 issue, Neurology is introducing a new clinical trials recruiting section organized by disease.

In the same issue, Neurology "Patient Page" editor Robin Brey, MD, a neurologist at the University of Texas in San Antonio, describes therapy advancements in stroke, epilepsy, Parkinson's disease, multiple sclerosis and migraine that were dependent on clinical research trials.

According to the Association of Clinical Research Professionals (www.acrpnet.org), close to 80 percent of clinical trials have problems in recruitment that delay or even prevent their completion.

Information about clinical research studies for neurological diseases is available on the Neurology Website at www.neurology.org, and on the National Institute of Neurological Diseases and Stroke Website at www.nih.ninds.gov.

The American Academy of Neurology, an association of more than 18,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as multiple sclerosis, restless legs syndrome, Alzheimer's disease, narcolepsy, and stroke.

For more information about the American Academy of Neurology, visit its Website at http://www.aan.com.

---

---